The lack of correlation between CAG repeat length, the disease burden, and the levels of total Tau and pTau‐231 suggests that the triggering mechanism of Tau‐related pathology in HD does not necessarily depend on the size of the expansion or the cumulative livelong exposure to the mutation. Here, MAPT is linked to Huntington disease.